Skip to content
HowShorted

Tectonic Therapeutic, Inc. short interest in 2020

In 2020, Tectonic Therapeutic, Inc.'s disclosed short interest ran from 2.23% of shares outstanding on 15 Jan 2020 to 9.73% on 31 Dec 2020, a change of +7.50 percentage points. The year's high was 9.73% on 31 Dec 2020 and its low 2.23% on 15 Jan 2020, averaging 6.28% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.99 days on 31 Aug 2020. Full history: Tectonic Therapeutic, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tectonic Therapeutic, Inc. in 2020

2020 in figures

Start of year
2.23% (15 Jan 2020)
End of year
9.73% (31 Dec 2020)
Change
+7.50 pp
High
9.73% (31 Dec 2020)
Low
2.23% (15 Jan 2020)
Average
6.28%
Highest days to cover
27.99 (31 Aug 2020)
SEC filings marked
9

Every report in 2020

Tectonic Therapeutic, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20202.23%6.18
31 Jan 20203.02%5.32
14 Feb 20204.65%2.72results (8-K)
28 Feb 20204.62%3.27
13 Mar 20204.31%6.42
31 Mar 20204.26%4.1810-K filed, results (8-K)
15 Apr 20205.04%6.64
30 Apr 20203.72%6.55
15 May 20204.02%4.4510-Q filed, results (8-K)
29 May 20204.79%4.49
15 Jun 20205.43%5.73
30 Jun 20206.68%5.58
15 Jul 20207.52%12.05
31 Jul 20207.92%13.71
14 Aug 20207.62%18.6010-Q filed, results (8-K)
31 Aug 20207.57%27.99
15 Sep 20207.68%21.05
30 Sep 20208.79%15.71
15 Oct 20208.52%14.96
30 Oct 20208.30%19.69
13 Nov 20208.43%16.9510-Q filed, results (8-K)
30 Nov 20208.14%6.04
15 Dec 20207.81%6.43
31 Dec 20209.73%13.79

See also: Tectonic Therapeutic, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.